FAT1 and acute myeloid leukemia: To study the impact of FAT1 mutations on the therapeutic outcomes and prognosis of AML patients, we first performed bioinformatics analysis of the FAT1 mutation spectrum in 205 patients from the ICGC public database LAML-KR cohort.